JPH0133450B2 - - Google Patents

Info

Publication number
JPH0133450B2
JPH0133450B2 JP55095167A JP9516780A JPH0133450B2 JP H0133450 B2 JPH0133450 B2 JP H0133450B2 JP 55095167 A JP55095167 A JP 55095167A JP 9516780 A JP9516780 A JP 9516780A JP H0133450 B2 JPH0133450 B2 JP H0133450B2
Authority
JP
Japan
Prior art keywords
pka
factor xii
isg
preparation
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55095167A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5616416A (en
Inventor
Aaru Zufui Teimoshii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Cutter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cutter Laboratories Inc filed Critical Cutter Laboratories Inc
Publication of JPS5616416A publication Critical patent/JPS5616416A/ja
Publication of JPH0133450B2 publication Critical patent/JPH0133450B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP9516780A 1979-07-16 1980-07-14 Immunizing serum globulin bend and its method Granted JPS5616416A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/057,880 US4272521A (en) 1979-07-16 1979-07-16 Purified immune serum globulin

Publications (2)

Publication Number Publication Date
JPS5616416A JPS5616416A (en) 1981-02-17
JPH0133450B2 true JPH0133450B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-07-13

Family

ID=22013311

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9516780A Granted JPS5616416A (en) 1979-07-16 1980-07-14 Immunizing serum globulin bend and its method

Country Status (3)

Country Link
US (1) US4272521A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5616416A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3025078A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE32011E (en) * 1981-12-14 1985-10-22 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4639513A (en) * 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
US5165938A (en) * 1984-11-29 1992-11-24 Regents Of The University Of Minnesota Wound healing agents derived from platelets
US4590002A (en) * 1984-12-10 1986-05-20 Ortho Diagnostic Systems, Inc. Methods for preparation of highly purified, gamma globulins free of hepatitis-B-virus infectivity
JPH0662435B2 (ja) * 1986-02-28 1994-08-17 株式会社ミドリ十字 免疫グロブリンの製造方法
JPH0662436B2 (ja) * 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
US4911910A (en) * 1986-11-25 1990-03-27 Biotech Research Labs, Inc. Purified equine immunologlobulins and method of use thereof
US5157113A (en) * 1987-08-10 1992-10-20 Miles Inc. Removal of nucleic acids from monoclonal antibody preparations
AT391810B (de) * 1988-02-26 1990-12-10 Immuno Ag Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators
US20080199513A1 (en) * 1997-06-24 2008-08-21 Cascade Medical Enterprises, Llc Systems and methods for preparing autologous fibrin glue
US6979307B2 (en) * 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
US7745106B2 (en) * 1997-06-24 2010-06-29 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components
ES2527915T3 (es) * 1998-06-09 2015-02-02 Csl Behring Ag Producto de inmunoglobulina G (IgG) líquido
WO1999066797A1 (en) 1998-06-22 1999-12-29 Worden Charles E Enriched platelet wound healant
FR2824568B1 (fr) * 2001-05-11 2004-04-09 Lab Francais Du Fractionnement Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique
EP1890820A4 (en) * 2005-03-22 2012-04-11 Cascade Medical Entpr Llc SYSTEMS AND METHOD FOR PRODUCING MEMBRANES
KR20110086184A (ko) 2008-12-22 2011-07-27 에프. 호프만-라 로슈 아게 면역글로불린 정제
FR2974301B1 (fr) * 2011-04-20 2013-08-23 Lab Francais Du Fractionnement Procede de preparation d'un produit plasmatique deplete en un ou plusieurs facteurs thrombogenes
IL212911A0 (en) * 2011-05-16 2011-07-31 Omrix Biopharmaceuticals Ltd Immunoglobulin reduced in thrombogenic contaminants and preparation thereof
CN110339209B (zh) * 2019-07-18 2023-06-06 上海泰坦科技股份有限公司 一种去甲状腺结合蛋白的小牛血清的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3717708A (en) * 1968-10-24 1973-02-20 Cutter Lab Blood coagulation complex
US3869436A (en) * 1971-06-01 1975-03-04 Statens Bakteriologiska Lab Method for fractionating plasma proteins using peg and ion-exchangers
IL43643A (en) * 1972-11-27 1976-10-31 Baxter Laboratories Inc Method for production of gamma globulin
US4137307A (en) * 1973-11-15 1979-01-30 The Green Cross Corporation Process for preparing haptoglobin aqueous solution using strong anion exchanger
CA1064396A (en) 1975-02-18 1979-10-16 Myer L. Coval Fractional precipitation of gamma globulin with polyethylene glycol
US4126605A (en) * 1975-12-29 1978-11-21 Plasmesco Ag Process of improving the compatibility of gamma globulins
US4165370A (en) * 1976-05-21 1979-08-21 Coval M L Injectable gamma globulin
US4075193A (en) * 1976-11-26 1978-02-21 Parke, Davis & Company Process for producing intravenous immune globulin
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
US4136094A (en) * 1977-08-31 1979-01-23 The Regents Of The University Of Minnesota Preparation of intravenous human and animal gamma globulins and isolation of albumin

Also Published As

Publication number Publication date
US4272521A (en) 1981-06-09
DE3025078A1 (de) 1981-02-05
JPS5616416A (en) 1981-02-17
DE3025078C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-02-18

Similar Documents

Publication Publication Date Title
JPH0133450B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
US4687664A (en) Method of inactivating reproducible pathogens
Jesty et al. Purification of Factor VII from bovine plasma: Reaction with tissue factor and activation of Factor X
Colowick [11] Separation of proteins by use of adsorbents
Hansbrough et al. Speract. Purification and characterization of a peptide associated with eggs that activates spermatozoa.
Rhinesmith et al. A quantitative study of the hydrolysis of human dinitrophenyl (DNP) globin: the number and kind of polypeptide chains in normal adult human hemoglobin
KR100201195B1 (ko) 알부민 제제 및 이의 제조방법
Polakoski et al. Boar Acrosin: I. PURIFICATION AND PRELIMINARY CHARACTERIZATION OF A PROTEINASE FROM BOAR SPERM ACROSOMES
US6485932B1 (en) Composition comprising immunoglobulin
JPS60215628A (ja) 血液生産物中の増殖性を有する濾過性病原体の不活性化法および血液生産物の製造方法
US4075193A (en) Process for producing intravenous immune globulin
JPH06107561A (ja) 静脈内相容性免疫グロブリン− ｇ− 製剤の製造方法
Ford et al. Purification and properties of a lymphocyte inhibition factor from human serum
Andersson et al. The effects of organic solvents and temperature on the desorption of yeast 3-phosphoglycerate kinase from immunoadsorbent
Heumann et al. Purification and immunological characterization of the human hexokinase isoenzymes I and III (ATP-D-hexose 6-phosphotransferase EC 2.7. 1.1)
Kumar et al. The acetylcholinesterase of Bungarus fasciatus venom
JPH0664B2 (ja) 化学的プロセス
Scarpelli et al. Protein and lipid-protein fractions of lung washings: immunological characterization.
Seegers et al. Isolation of platelet cofactor I from plasma and some properties of the preparation
Von Zabern et al. Effect of radiographic contrast media on complement components C3 and C4: generation of C3b-like C3 and C4b-like C4
JPH02180833A (ja) 蛋白質含有組成物の製造方法
EP0179485B1 (en) A process for the purification of hbsag
Wallin et al. Purification from bovine blood of the warfarin-induced precursor of prothrombin
JPH01258700A (ja) 血液凝固第４因子の精製方法
JPS62114919A (ja) 静注用免疫グロブリンの製法